Diabetic foot ulcers are among the most stubborn wounds in clinical medicine. They heal slowly, recur often, and remain a leading pathway to lower-limb amputation. Because conventional dressings alone frequently fail to close these wounds, clinicians have turned to a range of advanced therapies. One of the most widely adopted is negative pressure wound therapy (NPWT), also known as vacuum-assisted closure. This article explains how NPWT works, summarizes what recent peer-reviewed research says about its effectiveness for diabetic foot wounds, and describes where current clinical guidelines place it.
What Is Negative Pressure Wound Therapy?
NPWT involves sealing a wound with a foam or gauze dressing connected by tubing to a vacuum pump. The pump applies a controlled sub-atmospheric pressure — commonly around 125 mmHg, delivered continuously or in intermittent cycles — that draws wound and tissue fluid into a collection canister. The therapy is thought to work through several complementary mechanisms. It removes excess exudate and reduces localized swelling, gently draws the wound edges inward, applies microscopic mechanical stress to cells at the wound surface, and helps maintain a moist, contained environment. Together these effects are believed to stimulate the growth of healthy granulation tissue and support local blood flow. NPWT is used both on open diabetic foot ulcers and on the surgical wounds that remain after debridement or partial foot amputation.
What the Evidence Shows for Wound Healing
The most rigorous synthesis of trial data remains a Cochrane systematic review by Liu and colleagues (2018), which pooled 11 randomized controlled trials involving 972 adults. For diabetic foot ulcers, the review found that NPWT may increase the proportion of wounds that heal compared with standard dressings (risk ratio 1.40), and pooled data suggested that patients treated with NPWT may face a lower risk of amputation (risk ratio 0.33). For post-amputation surgical wounds, NPWT was associated with more wounds healed and a median time to healing roughly three weeks shorter than with moist dressings.
A 2025 systematic review and meta-analysis by Villalba-Aguilar and colleagues, published in the Journal of Clinical Medicine, reached broadly similar conclusions. Analyzing 11 trials with more than 1,100 participants, the authors reported that NPWT improves healing rates, accelerates the formation of granulation tissue, and reduces wound size compared with conventional treatment. They also noted that NPWT was associated with less pain and a reduced need for antibiotics and analgesics.
A More Nuanced Picture From Real-World Practice
Despite these encouraging findings, the evidence is not uniformly positive, and important caveats apply. The Cochrane authors graded all of their conclusions as low-certainty, reflecting limitations in trial size, design, and risk of bias. The 2025 meta-analysis similarly found no statistically significant difference between NPWT and conventional care in amputation or infection rates.
The clearest cautionary signal comes from the German DiaFu randomized controlled trial (Seidel and colleagues, 2020), one of the largest pragmatic studies of its kind. It compared NPWT with standard moist wound care across 40 specialized diabetes foot centers. Among the 345 patients analyzed, NPWT was not shown to be superior: neither the rate of wound closure nor the time to closure differed significantly between the groups. The investigators observed that overall closure rates were low and that documentation gaps and deviations from treatment protocols may have influenced the results — a reminder that any therapy performs only as well as the care system delivering it.
Where NPWT Fits in Current Guidelines
The 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on wound healing interventions reviewed the available evidence and issued a conditional recommendation: clinicians may consider NPWT to reduce wound size in people with diabetes who have a post-operative foot wound, as an addition to standard care. The guideline describes this as a weak recommendation supported by low-quality evidence, mirroring the uncertainty seen in the Cochrane review.
Crucially, NPWT is not a substitute for the fundamentals of diabetic wound management. Thorough debridement, control of infection, pressure offloading, and assessment of the foot’s blood supply remain essential. NPWT is generally avoided over wounds that have not been adequately debrided, over untreated osteomyelitis or actively infected tissue, and where blood vessels or other deep structures are exposed. Appropriate patient selection and expert clinical judgment are therefore central to using the therapy well.
Key Takeaways
Negative pressure wound therapy has earned a meaningful role in managing diabetic foot wounds, particularly complex surgical wounds following debridement or partial amputation. The best available evidence suggests it may help more wounds heal, speed granulation, and shorten healing time — but the certainty of that evidence is low, and a large pragmatic trial found no advantage over well-delivered standard care. The practical message is that NPWT works best as one carefully chosen component of a comprehensive strategy built on debridement, infection control, offloading, and vascular assessment, rather than as a stand-alone fix. Further high-quality trials are needed to clarify which patients stand to benefit most.
References
- Liu Z, Dumville JC, Hinchliffe RJ, Cullum N, Game F, Stubbs N, Sweeting M, Peinemann F. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2018;(10):CD010318.
- Villalba-Aguilar C, Laredo-Aguilera JA, Villalba-Aguilar L, Castillo-Hermoso MI, López-Fernández-Roldán Á, Carmona-Torres JM. Comparative efficacy of negative pressure wound therapy and conventional treatments in the management of diabetic foot ulcers: a systematic review and meta-analysis. Journal of Clinical Medicine. 2025;14(22):8051.
- Seidel D, Storck M, Lawall H, et al. Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT. BMJ Open. 2020;10(3):e026345.
- International Working Group on the Diabetic Foot. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024.
Comments
